Css LLC Danaher Corp Transaction History

Css LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$241.42 - $282.29 $531,124 - $621,038	-2,200 Reduced 8.25%	24,461 $6.49 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $4.05 Million - $24.7 Million	16,393 Added 159.65%	26,661 $6.89 Million
Q2 2022 Aug 15, 2022	SELL	$237.11 - $299.66 $2.54 Million - $3.21 Million	-10,713 Reduced 51.06%	10,268 $2.6 Million
Q1 2022 May 16, 2022	SELL	$257.27 - $315.76 $657,582 - $807,082	-2,556 Reduced 10.86%	20,981 $6.15 Million
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $4.4 Million - $4.96 Million	15,081 Added 178.35%	23,537 $7.74 Million
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $2.3 Million - $2.81 Million	8,456 New	8,456 $2.57 Million
Q3 2020 Nov 16, 2020	SELL	$177.16 - $215.33 $3.68 Million - $4.47 Million	-20,756 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$128.7 - $176.83 $2.67 Million - $3.67 Million	20,756 New	20,756 $3.67 Million
Q2 2019 Aug 14, 2019	SELL	$124.88 - $143.73 $456,186 - $525,045	-3,653 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$97.62 - $132.29 $356,605 - $483,255	3,653 New	3,653 $482,000

2,507

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.